Jun Wei is the founder of iRegene. iRegene has raised $42M in total funding. Latest round: Series B. Based in Wuhan, Hubei, China.
Dr. Jun Wei is the Founder and CEO of iRegene Therapeutics, a biotechnology company based in Chengdu, China. Established in 2017, iRegene Therapeutics specializes in developing chemically induced allogeneic cell therapies for incurable conditions such as Parkinson's disease and blindness. The company's flagship product, NouvNeu001, has received FDA Fast Track Designation. iRegene Therapeutics has raised over $40 million in funding across multiple rounds, including a Series B+ round.
Full founder directory · Investor directory · Company funding database · Fundraising library